Canna~Fangled Abstracts Targeting Cannabinoid 1 and Delta Opioid Receptor Heteromers Alleviates Chemotherapy-Induced Neuropathic Pain. ACS Pharmacol Transl Sci. 2019 Aug 9;2(4):219-229. doi: 10.1021/acsptsci.9b00008. Epub 2019 Jun 5. Sierra S1,…Freedom WaresJune 5, 2019
For Your Consideration... Increased expression of cannabinoid CB2 and serotonin 5-HT1A heteroreceptor complexes in a model of newborn hypoxic-ischemic brain damage. Neuropharmacology. 2019 Feb 6. pii: S0028-3908(19)30046-2. doi: 10.1016/j.neuropharm.2019.02.004. Franco R1, Villa M2, Morales P3, Reyes-Resina…Freedom WaresFebruary 6, 2019
Canna~Fangled Abstracts Targeting Cannabinoid CB2 Receptors in the Central Nervous System. Medicinal Chemistry Approaches with Focus on Neurodegenerative Disorders. 2016 Sep 13;10:406. doi: 10.3389/fnins.2016.00406. eCollection 2016. Navarro G1, Morales P2, Rodríguez-Cueto C3, Fernández-Ruiz J3, Jagerovic N4, Franco R1. Author…Freedom WaresSeptember 13, 2016
Canna~Fangled Abstracts One for the Price of Two…Are Bivalent Ligands Targeting Cannabinoid Receptor Dimers Capable of Simultaneously Binding to both Receptors? 2016 Feb 22. pii: S0165-6147(16)00024-9. doi: 10.1016/j.tips.2016.01.010. Glass M1, Govindpani K2, Furkert DP3, Hurst DP4, Reggio PH4, Flanagan JU5. Author…Freedom WaresFebruary 22, 2016
Canna~Fangled Abstracts Revolution in GPCR Signaling: Opioid receptor heteromers as novel therapeutic targets. 2014 Jun 10. doi: 10.1111/bph.12798. Revolution in GPCR Signaling: Opioid receptor heteromers as novel therapeutic…Freedom WaresJune 10, 2014
Canna~Fangled Abstracts G-Protein-Coupled Receptor Heteromers as Key Players in the Molecular Architecture of the Central Nervous System. 2014 May 9. doi: 10.1111/cns.12277. G-Protein-Coupled Receptor Heteromers as Key Players in the Molecular Architecture…Freedom WaresMay 9, 2014